• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reply to: "Letter to the Editor: Are ketamine-induced subjective bodily experiences associated with antidepressant effects? A sensation of floating and a sensation of Lightnessare not the same - A comment on Acevedo-Diaz et al." (Jpsychiatrres-D-21-00121).回复：“致编辑的信：氯胺酮诱导的主观身体体验与抗抑郁作用有关吗？漂浮感和轻盈感并不相同——对阿塞韦多 - 迪亚兹等人的评论”（《精神疾病研究杂志》-D-21-00121）
J Psychiatr Res. 2021 May;137:409-410. doi: 10.1016/j.jpsychires.2021.03.018. Epub 2021 Mar 16.
2
Letter to the editor: Are ketamine-induced subjective bodily experiences associated with antidepressant effects? A sensation of floating and a sensation of lightness are not the same - A comment on Acevedo-Diaz et al.
J Psychiatr Res. 2021 May;137:454-455. doi: 10.1016/j.jpsychires.2021.03.017. Epub 2021 Mar 16.
3
Reply to: Rapid antidepressant effects and abuse liability of ketamine.回复：氯胺酮的快速抗抑郁作用及滥用倾向
Psychopharmacology (Berl). 2014 May;231(9):2043-4. doi: 10.1007/s00213-014-3544-z.
4
Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder.在接受氯胺酮输注时出现焦虑与重度抑郁症的负面治疗反应有关。
Eur Neuropsychopharmacol. 2019 Apr;29(4):529-538. doi: 10.1016/j.euroneuro.2019.02.005. Epub 2019 Feb 13.
5
Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity.致编辑的信：R-氯胺酮：一种起效迅速且持续作用的抗抑郁药，无脑毒性风险。
Psychol Med. 2016 Aug;46(11):2449-51. doi: 10.1017/S0033291716000969. Epub 2016 Jun 10.
6
A letter to the editor, associated with the article entitled "Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketamine vs lithium" by Vázquez et al. (, 2021, Vol. 35(8) 890-900).一封致编辑的信，与巴斯克斯等人（2021年，第35卷第8期，890 - 900页）发表的题为《重度抑郁症联合治疗的疗效和耐受性：抗抑郁药加第二代抗精神病药与艾氯胺酮与锂盐对比》的文章相关。
J Psychopharmacol. 2022 May;36(5):653-654. doi: 10.1177/02698811221092504. Epub 2022 Apr 27.
7
Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor.氯胺酮与单胺氧化酶抑制剂联合用于治疗抑郁症：致编辑的一封信
Gen Hosp Psychiatry. 2018 Sep-Oct;54:62-64. doi: 10.1016/j.genhosppsych.2018.05.007. Epub 2018 May 22.
8
Rapid antidepressant effects and abuse liability of ketamine.氯胺酮的快速抗抑郁作用及滥用倾向
Psychopharmacology (Berl). 2014 May;231(9):2041-2. doi: 10.1007/s00213-014-3543-0. Epub 2014 Mar 26.
9
Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant.滥用氯胺酮作为速效抗抑郁药的相关风险。
Neurosci Bull. 2016 Dec;32(6):557-564. doi: 10.1007/s12264-016-0081-2. Epub 2016 Nov 22.
10
Letter to the editor about "Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis".致编辑的信：关于“消旋氯胺酮和艾氯胺酮治疗抑郁症的疗效比较：系统评价与荟萃分析”
J Affect Disord. 2023 Feb 1;322:1. doi: 10.1016/j.jad.2022.10.013. Epub 2022 Oct 18.

本文引用的文献

1
Can 'floating' predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression.“漂浮”能否预测氯胺酮治疗的反应？来自三项针对治疗抵抗性抑郁症个体的随机试验的数据。
J Psychiatr Res. 2020 Nov;130:280-285. doi: 10.1016/j.jpsychires.2020.06.012. Epub 2020 Jul 30.
2
The Altered-State-of-Consciousness Aspect of a Feeling of Lightness Is Reported to Be Associated with Antidepressant Benefits by Depressed Individuals Receiving Ketamine Infusions: A Systematic Analysis of Internet Video Testimonials.接受氯胺酮输注的抑郁症患者报告称，轻盈感的意识改变方面与抗抑郁效果相关：对网络视频推荐的系统分析
Psychother Psychosom. 2019;88(3):182-183. doi: 10.1159/000497441. Epub 2019 Mar 18.
3
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects.氯胺酮对抑郁和健康受试者具有明显的电生理和行为效应。
Mol Psychiatry. 2019 Jul;24(7):1040-1052. doi: 10.1038/s41380-018-0028-2. Epub 2018 Feb 27.
4
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.双相抑郁中氯胺酮抗抑郁疗效的复制：一项随机对照附加试验。
Biol Psychiatry. 2012 Jun 1;71(11):939-46. doi: 10.1016/j.biopsych.2011.12.010. Epub 2012 Jan 31.
5
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.一项关于 N-甲基-D-天冬氨酸拮抗剂治疗难治性双相抑郁的随机附加试验。
Arch Gen Psychiatry. 2010 Aug;67(8):793-802. doi: 10.1001/archgenpsychiatry.2010.90.

Reply to: "Letter to the Editor: Are ketamine-induced subjective bodily experiences associated with antidepressant effects? A sensation of floating and a sensation of Lightnessare not the same - A comment on Acevedo-Diaz et al." (Jpsychiatrres-D-21-00121).

作者信息

Acevedo-Diaz Elia E, Greenwald Maximillian, Cavanaugh Grace W, Greenstein Dede K, Kraus Christoph, Kadriu Bashkim, Zarate Carlos A, Park Lawrence T

机构信息

Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

出版信息

J Psychiatr Res. 2021 May;137:409-410. doi: 10.1016/j.jpsychires.2021.03.018. Epub 2021 Mar 16.

DOI:10.1016/j.jpsychires.2021.03.018
PMID:33773443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8223260/
Abstract
摘要